youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
EDIT:NASDAQ
Editas Medicine Inc
$2.57
arrow_upward
+0.78%(+0.020) 1D
$2.57
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 6, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.55
High
$2.63
Low
$2.48
Mkt. cap
394.70M
Avg. vol.
2.33M
Volume
1.72M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.09
Shares outstanding
153.58M
No. of employees
87
Open
$2.55
High
$2.63
Low
$2.48
Mkt. cap
394.70M
Avg. vol.
2.33M
Volume
1.72M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.09
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
Briefs Finance
·
8 hours ago
Inflation Mentions Hit S&P 500 Earnings Calls Peak
TradingView
·
11 hours ago
S&P 500 Consumer Discretionary Earnings: 89% beat EPS estimates this week
The Motley Fool
·
9 hours ago
This Dividend King Yielding 2X the S&P 500 Looks Like a Buy in November.
www.tmgm.com
·
1 day ago
United States CFTC S&P 500 NC Net Positions up to $-129.4K from previous $-134.4K
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com